When HAE runs in the family, TAKHZYRO may be an option

TAKHZYRO is the first and only preventive treatment indicated for children with HAE 2 years of age and older. This means it could be a preventive option for you and your family members with HAE.

Imageoverlay
Patient portrayal.

TAKHZYRO is the #1 prescribed preventive HAE treatment*

*Based on total patients on HAE preventive treatments according to US third-party industry healthcare data.

Prescribed to 4,000+ people since 2018†

†The number of patients prescribed TAKHZYRO is based on third-party US specialty pharmacy data.

Established safety profile from a 26-week study of 125 adults and adolescents (≥12 years of age) with HAE and a 52-week study of 21 children (2 to <12 years of age) with HAE. Learn more about the clinical study results.
Dosing once every 2 weeks for people 6 years of age and up, or every 4 weeks for children 2 to <6 years of age. Learn more about dosing.

When multiple members of the family are on TAKHZYRO, you can all navigate your treatment journey together.

Looking for information about TAKHZYRO for you or your family member with HAE?

DOWNLOAD

My daughter and I do our injections together—it’s a way for us to share the experience and support each other. It’s a routine that really works well for us.”

Eric

Real TAKHZYRO patient since 2020

I really like the fact that we're taking the same preventive treatment. Already being familiar with the administration process of TAKHZYRO is such a comfort."

SynToia

Real TAKHZYRO patient since 2021

Ready to talk to your doctor about TAKHZYRO for you or your family member with HAE?

START DOCTOR DISCUSSION GUIDE